Search

everythinglearnresearchcommunity

for

Search:↓

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Systemic lupus erythematosus is diagnosed earlier in males than females.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

SLE significantly affects daily life, especially through fatigue and joint pain, highlighting the need for better treatments.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Low BMI and cold exposure increase the risk of chilblains.

Dermoscopy and trichoscopy are useful for diagnosing skin signs in Dermatomyositis.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.